Your Location:
Home >
Browse articles >
Cell-free DNA in sepsis: from molecular insights to clinical management
REVIEW | Updated:2026-01-29
    • Cell-free DNA in sepsis: from molecular insights to clinical management

    • In the field of sepsis diagnosis and treatment, cell-free DNA (cfDNA) has emerged as a novel biomarker and molecular therapeutic target. Expert research has elucidated the release and pathological mechanisms of cfDNA in sepsis, laying a foundation for the development of targeted treatment strategies.
    • Military Medical Research   Vol. 12, (2025)
    • DOI:10.1186/s40779-025-00668-2    

      CLC:
    • Received:30 July 2025

      Accepted:01 November 2025

      Online First:02 December 2025

      Published:2025

    Scan QR Code

  • Lei Li, Hong-Chao Huang, Yin He, et al. Cell-free DNA in sepsis: from molecular insights to clinical management[J/OL]. Military Medical Research, 2025, 12. DOI: 10.1186/s40779-025-00668-2.

  •  
  •  

0

Views

0

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Exosomal mediators in sepsis and inflammatory organ injury: unraveling the role of exosomes in intercellular crosstalk and organ dysfunction
The "cytokine storm" in infection and sepsis:win the battle but lose the war
PRIME: an interpretable artificial intelligence model based on liquid biopsy improves prediction of progression risk in non-small cell lung cancer
Sepsis in burns: lessons learned, challenges remain
The emerging role of ferroptosis in the pathological development and progression of sepsis

Related Author

Ting Gong
You-Tan Liu
Jie Fan
Jiang-Bo Fan
Qin-Yuan Li
Xi-Feng Feng
Si-Yuan Huang
Rui Wang

Related Institution

Department of Surgery, University of Pittsburgh School of Medicine
Department of Anesthesiology, Shenzhen Hospital, Southern Medical University
Research and Development, Veterans Affairs Pittsburgh Healthcare System
Department of Immunology, University of Pittsburgh School of Medicine
McGowan Institute for Regenerative Medicine, University of Pittsburgh
0